/Investor DB

B Capital Group — 2019 Investments

5 investments dated 2019 · listed companies and verified rows first · show all

Impel Neuropharmaimpelneuropharma.comin𝕏Jun 2019SEC filingmedium confidence

Impel Pharmaceuticals develops therapies for diseases with high unmet medical needs by pairing established drugs with its proprietary upper-nasal drug delivery technology.

BiotechHealthtechMedical DevicesSeattle, US

John D. Hoekman(Executive Officer, Director)in

BoardMichael Hite(Director)Stewart Parker(Director)

Board seatRobert Mittendorff· per SEC Form D · $1.6M raise · filed Jul 2019

Co-investors5AM VenturesvenBio Global StrategicvenBio PartnersWestlake Village BioPartners

Neocisneocis.comin𝕏Jul 2019SEC filingmedium confidence

Neocis develops Yomi, a robotic surgical platform that assists clinicians during dental implant surgery with planning, surgical, and restorative software features.

HealthtechMedical DevicesRoboticsMiami, US

Alon Mozes(Founder)inJuan Salcedo(Founder)inDennis Moses(Chief Technical Officer)inAndres Carrillo(VP of Product)inJorge Fernandes(VP of Quality & Regulatory)inGabe Goldberg(VP of Marketing)in

Board seatRobert Mittendorff· per SEC Form D · $30M raise · filed Jul 2019

Co-investorsIntuitive VenturesNorwest Venture PartnersVivo CapitalCLI VenturesFlorida Opportunity FundMithril Capital Management+5 more

Innovaccerinnovaccer.comin𝕏Series B · Jan 2019 · $11M

Innovaccer offers Provider Copilot, an AI assistant that automates clinical documentation, pre-visit prep, medical scribing, and prior authorization workflows for healthcare providers and care teams.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechSan Francisco, US

Abhinav Shashank(Founder)inSandeep Gupta(Founder)inKanav Hasija(Founder)inWendy Rubas(Chief Legal and Compliance Officer of the Issuer)inScott Bruckner(Chief Financial Officer of the Issuer)Ankit Maheshwari(Chief Technology Officer of the Issuer)in

Co-investors500 GlobalB4 CapitalLightspeed India PartnersLightspeed Venture PartnersM12 (Microsoft's Venture Fund)OMERS Private Equity Inc.+9 more

Insilico Medicineinsilico.comin𝕏Sep 2019

Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development.

AI & Machine LearningBiotechDigital HealthHealthtechHong Kong, US

Aleksandrs Zavoronkovs(Executive Officer, Director)Alex Zavoronkov(Director)Alex Zhavoronkov(Founder)inAlex Aliper(President)inFeng Ren(Chief Scientific Officer, Executive Director & Co-CEO)in

BoardNisa Leung(Director)in

Co-investorsLilly Asia VenturesOrbiMedQiming Venture PartnersWarburg PincusBaidu VenturesEight Roads Ventures+13 more

Specrightspecright.comin𝕏Series A · Apr 2019 · $9M

Specright provides an AI-powered, spec-first product lifecycle management (PLM) platform for managing specifications, formulas, ingredients, packaging, and bills of materials across food & beverage, beauty, consumer goods, industrials, life sciences, and quick service restaurants.

Advanced ManufacturingAI & Machine LearningEnterprise SoftwareSaaSIrvine, US

Matthew Wright(Founder & Executive Chairman)

BoardGabe Greenbaum(Director)Marc Averitt(Director)in

Co-investorsFikaMucker CapitalNew Earth VenturesOkapi Venture CapitalSageview CapitalFika Ventures+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.